Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1.
Gafni RI, Hartley IR, Roszko KL, Nemeth EF, Pozo KA, Lombardi E, Sridhar AV, Roberts MS, Fox JC, Collins MT. Gafni RI, et al. Among authors: fox jc. N Engl J Med. 2023 Sep 28;389(13):1245-1247. doi: 10.1056/NEJMc2302708. N Engl J Med. 2023. PMID: 37754292 Free PMC article. No abstract available.
Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.
Roszko KL, Stapleton Smith LM, Sridhar AV, Roberts MS, Hartley IR, Gafni RI, Collins MT, Fox JC, Nemeth EF. Roszko KL, et al. Among authors: fox jc. J Bone Miner Res. 2022 Oct;37(10):1926-1935. doi: 10.1002/jbmr.4659. Epub 2022 Aug 22. J Bone Miner Res. 2022. PMID: 35879818 Free PMC article.
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.
Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Jüppner H, D'Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J. Bilezikian JP, et al. J Bone Miner Res. 2011 Oct;26(10):2317-37. doi: 10.1002/jbmr.483. J Bone Miner Res. 2011. PMID: 21812031 Free PMC article.
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial.
Judge DP, Gillmore JD, Alexander KM, Ambardekar AV, Cappelli F, Fontana M, García-Pavía P, Grodin JL, Grogan M, Hanna M, Masri A, Nativi-Nicolau J, Obici L, Hvitfeldt Poulsen S, Sarswat N, Shah K, Soman P, Lystig T, Cao X, Wang K, Pecoraro ML, Tamby JF, Katz L, Sinha U, Fox JC, Maurer MS. Judge DP, et al. Among authors: fox jc. Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072771. Online ahead of print. Circulation. 2024. PMID: 39556242 Free article.
Effect of Acoramidis on Myocardial Structure and Function in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Cardiac Magnetic Resonance (CMR) Substudy.
Razvi Y, Judge DP, Martinez-Naharro A, Ioannou A, Venneri L, Patel R, Gillmore JD, Kellman P, Edwards L, Taubel J, Du J, Tamby JF, Castaño A, Siddhanti S, Katz L, Fox JC, Fontana M. Razvi Y, et al. Among authors: fox jc. Circ Heart Fail. 2024 Oct 28:e012135. doi: 10.1161/CIRCHEARTFAILURE.124.012135. Online ahead of print. Circ Heart Fail. 2024. PMID: 39465243 Free article. No abstract available.
Acoramidis in Transthyretin Amyloid Cardiomyopathy. Reply.
Gillmore JD, Lystig T, Fox JC. Gillmore JD, et al. Among authors: fox jc. N Engl J Med. 2024 Apr 11;390(14):1346-1347. doi: 10.1056/NEJMc2401669. N Engl J Med. 2024. PMID: 38598813 No abstract available.
288 results